Fundz

Neuble AI raises $269K in seed funding from Futureplay to advance AI-powered brain diagnostics and develop high-precision tools.

PRIVATEJul 16, 2026

Amount Raised

$269,000

Round Type

Seed

South KoreaBiotechnologyHealth CareArtificial IntelligenceMedicalMedical DeviceMachine LearningHealth Diagnostics

Investors

Futureplay

Description

Neuble AI, a Korean startup, has raised a seed round of $269K led by Futureplay. This funding will enhance their AI-based diagnostic systems for brain diseases. Their first product, BrainCura, aims to transform brain volumetric measurement through AI technology. The company plans to launch BrainCura by 2027, addressing the growing demand for early diagnosis in an aging population.

Who else raised in Medical and Medical Device around the same time

Companies in the same sectors as Neuble AI that raised within 45 days of this round, from Fundz verified event records.

  • Mediqstar raised an undisclosed amount (Series B) on August 3, 2026.
  • Uncovr raised $7M (Seed) on June 10, 2026.
  • Odysight.ai raised $11M (Post-IPO Equity) on August 21, 2026.
  • Nano-X Imaging Ltd. raised $8M (Post-IPO Equity) on August 6, 2026.
  • TidalSense raised $19M on July 24, 2026.
  • Telepatía AI raised $33M (Series A) on July 9, 2026.

Who to call at Neuble AI, and when

A new round usually means Neuble AI is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Neuble AI raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Neuble AI, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Neuble AI. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Neuble AI

Location

South Korea

About

Neuble AI is a MedTech startup that supports the diagnosis and treatment of brain diseases through proprietary medical AI technology, founded by a team of clinicians and researchers. The company combines hands-on clinical experience with technical expertise to develop AI-powered diagnostic and analysis solutions for brain diseases. With its first product, BrainCura, Neuble AI addresses the demand for precise diagnosis and early screening of degenerative brain conditions. The company aims to establish a medical ecosystem integrating checkup centers, dementia care centers, and university hospitals.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Neuble AI raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Neuble AI's next move

See what Strategic adds

Neuble AI raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.